Sunshine Biopharma, Inc. (OTCMKTS:SBFM) closed lower on Thursday.
On Thursday, SBFM stock closed lower by 8.73% at $0.1067. More than 4.50 million shares exchanged hands for the day, compared to its average volume of 3.77 million shares. The stock opened at $0.106 and moved within a range of $0.0971 – 0.1180.
SBFM Announced News
Sunshine Biopharma Eliminates $250,000 in Variable Rate Convertible Debt and Provides an Update on Status of OTCQB Uplisting
- SBFM announced that it has paid off $250,000 in variable rate convertible debt and is planning to soon eliminate the two similar items remaining on the books of the Company.
- The Company’s application for uplisting to the OTCQB had been declined due to outstanding variable rate loans which were on the Company’s financial statements at the time of the application. The Company can re-apply in October 2021.
Sunshine Biopharma’s CFO, Camille Sebaaly stated, “We are in the process of getting rid of these loans to minimize dilution. Protecting the shareholders against harmful dilution is of utmost importance to the management of Sunshine Biopharma.”
|SHARES OUTSTANDING||480.51 M|
|SHARE FLOAT (%)||406.68 M (84.64%)|
|% HELD BY INSTITUTIONS||–|
Recent Stock Performance
|+/- EMA(20)||1.56 (-16.67%)|
|+/- SMA(50)||1.78 (-26.97%)|
|+/- SMA(200)||1.26 (+3.17%)|
|CCI20||-121.6736||Sell||Chaikin Money Flow||-0.1431||Sell|
|MACD||-0.0070||Sell||Money Flow Index||47.7528||Buy|
|STOCH (14,3)||15.7546||OverSold||STOCH RSI||0.3013||Neutral|